University of Colorado Boulder 1002173570

Brilliant Violet 785™ anti-human HLA-DR; Brilliant Violet 650™ anti-human Ki-67; Alexa Fluor® 647 anti-human Granzyme...

This award involves the University of Colorado Boulder purchasing various immunology research reagents from BioLegend Inc under a single contract awarded on August 7, 2025. The ordered items include multiple fluorescently labeled antibodies, cell isolation kits, and streptavidin reagents, totaling an obligated amount of $4,648.95. The procurement was for laboratory research purposes within the university's department, located in Boulder, Colorado. BioLegend Inc is the vendor that received the award, and the purchase was part of the university's research project in the medical or scientific field.

Description

Brilliant Violet 785™ anti-human HLA-DR; Brilliant Violet 650™ anti-human Ki-67; Alexa Fluor® 647 anti-human Granzyme K; PerCP/Cyanine5.5 anti-human/mouse Granzyme B Recombinant; PE/Cyanine7 anti-human CD137 (4-1BB); Alexa Fluor® 700 anti-human CD8; Human CD8 Memory T Cell Isolation Kit; APC/Cyanine7 anti-human CD39; Spark UV™ 387 anti-human CD69 (Flexi-Fluor™); Brilliant Violet 650™ Streptavidin; Brilliant Violet 510™ anti-human CD3; Alexa Fluor® 594 anti-Nur77; Human CD8 Naïve T Cell Isolation Kit; Spark Blue™ 574 Streptavidin; Spark Violet™ 538 Streptavidin